Atopic dermatitis

46,609views

Atopic dermatitis

Watch later

Watch later

Development of the muscular system
Erb-Duchenne palsy
Klumpke paralysis
Thoracic outlet syndrome
Muscles of the thoracic wall
Vessels and nerves of the thoracic wall
Winged scapula
Brachial plexus
Carpal tunnel syndrome
Anatomy clinical correlates: Wrist and hand
Vessels and nerves of the hand
Muscle weakness: Clinical
Vessels and nerves of the forearm
Muscles of the forearm
Anatomy clinical correlates: Median, ulnar and radial nerves
Muscles of the hand
Fascia, vessels and nerves of the upper limb
Baker cyst
Myotonic dystrophy
Bursitis
Unhappy triad
Meniscus tear
Superficial structures of the neck: Anterior triangle
Iliotibial band syndrome
Neurocutaneous disorders: Pathology review
Bones of the lower limb
Bones of the upper limb
Anatomy of the anterior and medial thigh
Necrotizing fasciitis
Skin cancer: Clinical
Bone tumors: Pathology review
Neuromuscular junction disorders: Pathology review
Legg-Calve-Perthes disease
Pediatric orthopedic conditions: Clinical
Restless legs syndrome
Anatomy of the leg
Osgood-Schlatter disease (traction apophysitis)
Developmental dysplasia of the hip
Anatomy of the hip joint
Anatomy of the orbit
Patellofemoral pain syndrome
Anatomy of the elbow joint
Joints of the ankle and foot
Femoral hernia
Achondroplasia
Lower back pain: Clinical
Osteoporosis
Osteoporosis medications
Back pain: Pathology review
Lordosis, kyphosis, and scoliosis
Osteopetrosis
Osteomalacia
Osteomalacia and rickets
Paget disease of bone
Acute tubular necrosis
Bones of the cranium
Bones of the neck
Pediatric bone tumors: Clinical
Bone histology
Bone remodeling and repair
Seronegative arthritis: Clinical
Seronegative and septic arthritis: Pathology review
Reactive arthritis
Juvenile idiopathic arthritis
Joint pain: Clinical
Gout
Gout and pseudogout: Pathology review
Non-steroidal anti-inflammatory drugs
Sjogren syndrome: Clinical
Sjogren syndrome
Sjogren syndrome: Pathology review
Pediatric bone and joint infections: Clinical
Pasteurella multocida
Bites and stings: Clinical
Spondylitis
Cauda equina syndrome
Systemic lupus erythematosus (SLE): Clinical
Skin and soft tissue infections: Clinical
Antiphospholipid syndrome
Systemic lupus erythematosus (SLE): Pathology review
Fibromyalgia
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Raynaud phenomenon
Cholinomimetics: Indirect agonists (anticholinesterases)
Scleroderma: Pathology review
Scleroderma
Skin histology
Skin cancer: Pathology review
Hypersensitivity skin reactions: Clinical
Hair, skin and nails
Acneiform skin disorders: Pathology review
Benign hyperpigmented skin lesions: Clinical
Pigmentation skin disorders: Pathology review
Blistering skin disorders: Clinical
Papulosquamous and inflammatory skin disorders: Pathology review
Vesiculobullous and desquamating skin disorders: Pathology review
Eczematous rashes: Clinical
Body focused repetitive disorders
Cellulitis
Seborrhoeic dermatitis
Malassezia (Tinea versicolor and Seborrhoeic dermatitis)
Atopic dermatitis
Contact dermatitis
Papulosquamous skin disorders: Clinical
Hypokinetic movement disorders: Clinical
Movement disorders: Pathology review
Actinic keratosis
Hypopigmentation skin disorders: Clinical
Angiosarcomas
Human herpesvirus 8 (Kaposi sarcoma)
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Impetigo
Erysipelas
Orbital cellulitis
Periorbital cellulitis
Abscesses
Osteomyelitis
Periapical lesions
Staphylococcus aureus
Herpesvirus medications
Herpes simplex virus
Poxvirus (Smallpox and Molluscum contagiosum)
Varicella zoster virus
Epstein-Barr virus (Infectious mononucleosis)
Autoimmune bullous skin disorders: Clinical
Sarcoidosis
Pityriasis rosea
Rosacea
Sunburn
Burns: Clinical
Burns
Acetaminophen (Paracetamol)
Paracetamol toxicity
Bronchodilators: Leukotriene antagonists and methylxanthines
Cholinomimetics: Direct agonists
Skeletal muscle histology
Mechanisms of antibiotic resistance
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Fluoroquinolones
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Miscellaneous cell wall synthesis inhibitors
Antituberculosis medications
Antimetabolites: Sulfonamides and trimethoprim
Protein synthesis inhibitors: Aminoglycosides
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Azoles
Echinocandins
Miscellaneous antifungal medications
Anthelmintic medications
Antimalarials
Anti-mite and louse medications

Transcript

Watch video only

With atopic dermatitis, dermatitis refers to skin inflammation, while “atopic” comes from the Greek word “atopia” meaning “out of place”. This phrase reflects the idea that in atopic dermatitis, the immune system overreacts to everyday, harmless substances, such as dust and pollen, as if they were dangerous, subsequently triggering inflammation and an extremely itchy rash. Atopic dermatitis, also known as atopic eczema, is a chronic, relapsing skin condition that’s particularly common among young children, but it can also persist well into adulthood.

Now, the skin is the body’s natural barrier that protects you from environmental substances and microbes. The outer layer of your skin called the epidermis, has four layers stacked up like a protective team. At the bottom is the stratum basale, followed by the stratum spinosum, then the stratum granulosum. The outermost layer and the front line of the skin barrier is the stratum corneum. Think of it as a brick wall. In this wall, bricks represent dead, flattened skin cells called corneocytes, which lock in moisture and keep allergens, irritants, and microbes out. But even the strongest wall needs reinforcement, and that’s where filaggrin comes in. This special protein works like rebar inside the wall. It links neighboring cells, flattens them out, and gives the skin its strength and flexibility.

At the heart of atopic dermatitis is a complex interaction between genetics, environmental factors, and the immune system.

On the genetic side, many individuals have mutations in the gene that encodes filaggrin. Without enough functional filaggrin, the wall loses its strength and cracks open leaving our body vulnerable. In other words, the skin loses its ability to retain moisture and keep out harmful substances.

Moreover, this compromised skin barrier opens the door to environmental triggers and allergens, such as dust mites and pollen. But here’s the thing. The immune system is always on alert, with antigen-presenting cells as frontline scouts constantly gathering intelligence on potential threats.

So, when something makes its way through the damaged skin, these immune scouts spring into action. They capture the intruder through a process called phagocytosis and break it down. Next, they present some of its fragments, known as antigens, on their surface. It’s their way of signalling to the immune system: “We have an intruder!” Using these antigens, they alert Th2 helper T cells to release pro-inflammatory cytokines called interleukins, which signal other immune cells to jump into action.

Interleukin 5 activates eosinophils to join the response, while interleukins 4 and 13 stimulate B cells to differentiate into plasma cells. Next, these plasma cells begin producing allergen-specific IgE antibodies, which latch onto mast cells and prepare them for future encounters.

When the body meets the same allergen again, the allergen cross-links the IgE on the surface of mast cells, triggering the release of histamine and other inflammatory mediators. This IgE-mediated immune response, known as type I hypersensitivity, results in the hallmark symptoms of atopic dermatitis, including erythema, swelling, and intense itching. Itching leads to scratching, and scratching makes things worse by further damaging the already fragile skin barrier.

Additionally, a sneaky bacterium called Staphylococcus aureus takes advantage of the cracked skin. The bacterium colonizes damaged areas and releases toxins that stimulate the immune system even more, adding fuel to the already raging fire of inflammation.

But the immune system doesn’t stop at the skin. If a person keeps encountering the same allergen, the reaction can escalate, and the immune response can spread beyond the skin. This occurs when Th2 cells slip into the bloodstream and travel to the lungs, where they can trigger asthma. Later, they can reach the nasal passages and cause allergic rhinitis. This step-by-step progression is called the atopic march.

Sources

  1. "Robbins Basic Pathology. ISBN 0323353177 " Elsevier (2017-03-28)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2) ISBN: 1259644030" McGraw-Hill Education (2018-08-13)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E. ISBN: 1260026507" McGraw-Hill Education (2018-11-26)
  4. "Atopic Dermatitis: Skin-Directed Management. 134(6), e1735-e1744. " Pediatrics (2014)
  5. "Management of difficult and severe eczema in childhood. 345(jul23 2), e4770-e4770. " BMJ (2012)